2.2 Neuropathy & Monofilament Testing in Diabetic Patients

Neuropathy & Monofilament Testing in Diabetic Patients

Diabetic Peripheral Neuropathy (DPN) affects up to 50% of individuals with long-standing diabetes mellitus and is the leading predisposing factor for diabetic foot ulceration (DFU) and non-traumatic lower extremity amputation. Neuropathy deprives the patient of early warning signals, permitting repetitive mechanical shear and pressure to cause tissue breakdown unnoticed. Clinical assessment requires systematically evaluating the triad of diabetic nerve damage and quantifying Loss of Protective Sensation (LOPS).

---

Pathophysiology: The Neuropathic Triad

Chronic hyperglycemia induces nerve ischemia, oxidative stress, and accumulation of advanced glycation end-products (AGEs), leading to progressive damage across three distinct nerve fiber pathways:

1. Sensory Neuropathy (Small & Large Fibers):
   • Distal symmetric "glove-and-stocking" sensory loss.
   • Deprives the individual of pain and temperature awareness.
   • Allows repetitive minor trauma (e.g., a small stone in a shoe or tight footwear) to cause painless tissue ulceration.
2. Motor Neuropathy (Motor Nerve Fibers):
   • Causes atrophy of intrinsic foot musculature (lumbricals and interossei).
   • Results in muscle imbalance, flexor tendon pull dominance, and structural deformities such as claw toes, hammer toes, and prominent metatarsal heads.
   • Alters gait kinematics and significantly shifts plantar peak pressure points directly onto unpadded bony prominences.
3. Autonomic Neuropathy (Sympathetic Fibers):
   • Causes loss of sweat gland function (anhidrosis) and reduced sebaceous secretion.
   • Results in dry, hyperkeratotic, fissured skin prone to cracking and bacterial entry.
   • Disrupts microvascular tone, leading to arteriovenous shunting, warm dry skin, and bone demineralization associated with Charcot neuroarthropathy.

---

Semmes-Weinstein Monofilament Examination (SWME)

The 10-gram Semmes-Weinstein Monofilament (calibrated size 5.07) is the gold-standard bedside screening instrument for identifying Loss of Protective Sensation (LOPS).

  Monofilament Testing Technique:
  
     Clinician Hand          Monofilament (5.07 / 10g)
        [====]---------------\ 
                              \  (Perpendicular application)
                               \  Buckles for 1.5 seconds
                                V
                        ================= Skin Surface

Clinical Testing Protocol

1. Patient Orientation: Place the patient in a comfortable supine or seated position. Demonstrate the test by applying the monofilament to the patient's forearm or hand so they understand the sensation.
2. Testing Conditions: Instruct the patient to close their eyes and say "yes" whenever they feel the pressure touching their foot.
3. Application Technique:
   • Hold the monofilament perpendicular (90°) to the skin surface.
   • Apply steady pressure until the monofilament bends or buckles into a C-shape.
   • Maintain the buckled pressure against the skin for approximately 1.5 seconds, then release.
   • Do not slide the monofilament across the skin or apply it rapidly in a repetitive tapping movement.
4. Diagnostic Criteria for LOPS:
   • Testing is performed across 10 standard anatomical sites per foot.
   • Failure to feel the monofilament at 2 or more sites out of 10 establishes a diagnosis of Loss of Protective Sensation (LOPS).

---

The 10-Point Monofilament Site Map & Exclusions

The standard clinical examination checks 9 plantar locations and 1 dorsal location per foot:

1. Plantar distal phalanx of the 1st digit (hallux)
2. Plantar distal phalanx of the 3rd digit
3. Plantar distal phalanx of the 5th digit
4. Plantar surface of the 1st metatarsal head
5. Plantar surface of the 3rd metatarsal head
6. Plantar surface of the 5th metatarsal head
7. Plantar midfoot medial border
8. Plantar midfoot lateral border
9. Plantar surface of the heel
10. Dorsal web space between the 1st and 2nd toes

Critical Testing Rule: NEVER apply the monofilament directly over hyperkeratotic calluses, open wounds, surgical scars, or necrotic tissue. Thick callus tissue absorbs the 10g force and produces false-negative results. Test immediately adjacent to calluses or ulcers on intact, normal-thickness skin.

---

Advanced Neurological Assessment Modalities

While the 10g monofilament evaluates coarse tactile sensation, comprehensive neurological workups incorporate additional modalities to detect early nerve damage:

• 128 Hz Tuning Fork (Vibratory Perception): Applied to the bony prominence of the distal hallux interphalangeal joint. The clinician notes whether the patient perceives vibration and performs a timed disappearance test compared to their own hand.
• Biothesiometer / Vibration Perception Threshold (VPT): A quantitative electronic device delivering variable amplitude 100 Hz vibrations to the hallux or metatarsal heads:
  • VPT < 15 Volts: Normal vibratory sensitivity.
  • VPT 15 – 25 Volts: Moderate vibratory loss.
  • VPT > 25 Volts: Severe large-fiber sensory neuropathy; associated with a >7-fold increase in foot ulceration risk.
• Pinprick & Temperature Testing: Evaluates small-fiber spinothalamic nerve tract integrity using cold/warm probes or sterile safety pins.
• Achilles Tendon Reflex (Ankle Jerk): Evaluates deep tendon reflex integrity (S1 root), which is typically lost early in DPN.